Bone Biologics Corporation (BBLG) vs PMGC Holdings Inc. (ELAB)
A side-by-side comparison of Bone Biologics Corporation and PMGC Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BBLG
Bone Biologics Corporation
$0.47HealthcareDelayed quote: Oct 6, 2026, 2:12 PM EDT
ELAB
PMGC Holdings Inc.
$3.24HealthcareDelayed quote: Oct 6, 2026, 2:09 PM EDT
Total return — BBLG vs ELAB
growth of $100 · dividends reinvested · last 3yBBLG -98.3% (-74.2%/yr)ELAB -100.0% (-99.4%/yr)BBLG compounded faster over this window
Log scale — wide-divergence pair
BBLG ELAB
BBLG vs ELAB: by the numbers
- •ELAB is the larger company ($1M vs $857758 market cap).
- •Both run net losses; BBLG's is the smaller (0.00% vs -522.97% net margin).
Metrics side by side
Valuation
| Metric | BBLG | ELAB |
|---|---|---|
| P/S ratio | N/A | 0.57 |
| P/B ratio | 0.22 | 0.09 |
Profitability
| Metric | BBLG | ELAB |
|---|---|---|
| Gross margin | 0.00% | 10.31% |
| Operating margin | 0.00% | -1250.11% |
| Net margin | 0.00% | -522.97% |
| ROE | -73.66% | -80.57% |
| ROIC | -78.01% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.